Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisStem CellsCytarabineHodgkin DiseaseGranulocytesDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateWhole-Body IrradiationTime FactorsInfectionSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPlatelet CountPOEMS SyndromeCarboplatinPrednisoneHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneRecombinant ProteinsVidarabineFollow-Up StudiesBlood Cell CountLeukemiaAntineoplastic AgentsBone Marrow PurgingBlood CellsLymphomaProspective StudiesCytomegalovirus InfectionsGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesAnemia, AplasticImmunophenotypingBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionBone MarrowT-LymphocytesLeukocytes, MononuclearHematologic DiseasesHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisHLA AntigensBlood DonorsBreast NeoplasmsCyclosporineCell SeparationImmunosuppression